Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects

Journal of Magnetic Resonance Imaging

Volumn 25, Issue 6, 2007, Pages 1283-1287

  Krombach, Gabriele A ^a   Hahn, Christa ^a   Tomars, Maren ^a   Buecker, Arno ^a   Grawe, Armin ^a   Günther, Rolf W ^a   Kühl, Harald P ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Amyloidosis; Cardiac magnetic resonance imaging; Restrictive cardiomyopathy; T1 quantification; Tissue characterization

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HEART AMYLOIDOSIS; HEART FUNCTION; HEART VALVE; HEART VENTRICLE FILLING; HEART VENTRICLE WALL; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RESTRICTIVE CARDIOMYOPATHY; SYSTOLE;

AMYLOIDOSIS; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 34249876221     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20917     Document Type: Article

References (10)

1. Kholova I, Niessen HW. Amyloid in the cardiovascular system: a review. J Clin Pathol 2005;58:125-133.
2. Papachan A, Sliwa K, Gildenhuys A, Essop R. Cardiac amyloidosis presenting as pseudo-hypertrophic cardiomyopathy. Cardiovasc J S Afr 2004;15:136-138.
3. Fattori R, Rocchi G, Celletti F, Bertaccini P, Rapezzi C, Gavelli G. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy. Am Heart J 1998;136:824-830.
4. Flacke SJ, Fischer SE, Lorenz CH. Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Radiology 2001;218:703-710.
5. Celletti F, Fattori R, Napoli G, et al. Assessment of restrictive cardiomyopathy of amyloid or idiopathic etiology by magnetic resonance imaging. Am J Cardiol 1999;83:798-801, A10.
6. Look DC, Locker DL. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 1970;41:250-251.
7. Wagenseil JE, Johansson LO, Lorenz CH. Characterization of T1 relaxation and blood-myocardial contrast enhancement of NC100150 injection in cardiac MRI. J Magn Reson Imaging 1999; 10:784-789.
8. von Kemp K, Beckers R, Vandenweghe J, Taeymans Y, Osteaux M, Block P. Echocardiography and magnetic resonance imaging in cardiac amyloidosis. Acta Cardiol 1989;44:29-36.
9. Benson L, Hemmingsson A, Ericsson A, et al. Magnetic resonance imaging in primary amyloidosis. Acta Radiol 1987;28:13-15.
10. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:186-193.